Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes
Completed · Phase 1/Phase 2
Conditions studied: Diabetes, Gestational
In brief
Diabetic pregnant patients are at risk for adverse pregnancy outcomes, including larger than expected fetuses and unplanned operative deliveries, due to elevated blood glucose levels. the one-hour glucola test is currently used to screen pregnant patients for gestational diabetes. This involves ingesting a 50-gram glucose load, followed by a blood test one hour later. We wish to compare 7-day continuous glucose monitoring to the one-hour glucola test, and determine which one correlates better with adverse pregnancy outcomes as well as which one more accurately identifies patients at risk for adverse pregnancy outcomes.
Key facts
- Study ID
- NCT00850135
- Run by
- Stanford University
- People needed
- 57
- Starts
- 2009-02-01
- Expected to finish
- 2015-09-01
- Last updated by the study team
- 2016-05-19
Who can join
Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Pregnant patients
- Age 18-50
- Gestational age less than 28 weeks
You may not qualify if…
- Minors less than 18 years of age
- Multiple gestation
- Known fetal anomalies
Where it is running
- Santa Clara Valley Medical Center — San Jose, California, United States
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.